ISI OR TMI? BALANCING SAFETY AND UX IN ... ISI OR TMI? BALANCING SAFETY AND UX IN PHARMA’S DIGITAL FUTURE ISI OR TMI? BALANCING SAFETY AND UX IN PHARMA’S DIGITAL FUTURE
3
min read
9
min read
A Strategic Shift in Search: What Google’s ... A Strategic Shift in Search: What Google’s AI Overviews Mean for Healthcare Brands A Strategic Shift in Search: What Google’s AI Overviews Mean for Healthcare Brands
Search is undergoing its most significant transformation since the launch of Google. With the ...
6
min read
Unlocking the Future of Cancer Care: My Key ... Unlocking the Future of Cancer Care: My Key Takeaways From ASCO 2025 Unlocking the Future of Cancer Care: My Key Takeaways From ASCO 2025
The recently concluded American Society of Clinical Oncology (ASCO) 2025 Annual Meeting in Chicago, ...
7
min read
ASCO 2025: Preparing for the tumor’s next ... ASCO 2025: Preparing for the tumor’s next move ASCO 2025: Preparing for the tumor’s next move
As a molecular signaling aficionado, I have long been fascinated by the behavior of cells and their ...
4
min read
What I Took Away From My First ASCO—and Why ... What I Took Away From My First ASCO—and Why It Matters for Pharma Brand Builders What I Took Away From My First ASCO—and Why It Matters for Pharma Brand Builders
Over the course of my career (more years than I care to count), I have had the privilege of ...
4
min read
ASCO 2025: Data Differentiation & the Future ... ASCO 2025: Data Differentiation & the Future of Oncology Education ASCO 2025: Data Differentiation & the Future of Oncology Education
In my nearly 30 years in medical education, I’ve had the privilege of helping shape how healthcare ...
4
min read
Looking Ahead to ASCO 2025: What Oncology ... Looking Ahead to ASCO 2025: What Oncology Innovation Means for Pharma Brands Looking Ahead to ASCO 2025: What Oncology Innovation Means for Pharma Brands
As EVP, Managing Director of Client Partnerships at RevHealth, I’ve had the privilege of working ...
5
min read
Undercurrents at ASCO: The Innovation that ... Undercurrents at ASCO: The Innovation that May Hide and Why It Matters Undercurrents at ASCO: The Innovation that May Hide and Why It Matters
With ASCO 2025 just days away, I’m dusting off my conference-friendly shoes and preparing to join ...
4
min read
CEO as Influencer: Why Pharma Leaders Belong ... CEO as Influencer: Why Pharma Leaders Belong on Social CEO as Influencer: Why Pharma Leaders Belong on Social
Modern business leadership requires an evolving communication skill set. For executives with ...
6
min read
The Soul of the Machine: Curation & ... The Soul of the Machine: Curation & Expertise in AI Pharma Marketing The Soul of the Machine: Curation & Expertise in AI Pharma Marketing
The landscape of pharmaceutical marketing is meeting a new day with artificial intelligence (AI) ...
4
min read
Oncology Brand Marketing in a Rep-Challenged ... Oncology Brand Marketing in a Rep-Challenged Era Oncology Brand Marketing in a Rep-Challenged Era
The pharmaceutical industry is undergoing a paradigm shift, moving away from traditional rep-based ...
5
min read
Cross-Functional Communication Leads to ... Cross-Functional Communication Leads to Favorable Access Cross-Functional Communication Leads to Favorable Access
The complexities associated with market access today are evolving at a pace commensurate with the ...
3
min read
ChatGPT in Pharma: A Year of Generative ... ChatGPT in Pharma: A Year of Generative Innovation ChatGPT in Pharma: A Year of Generative Innovation
One year ago, two powerful generative AI models entered the market: OpenAI and ChatGPT. In the time ...